Mark A. Dawson - Concepedia

Author

Mark A. Dawson

Also Known As

Bethany Davis, Dawson, Mark, Dawson, Mark A, Dawson, Mark A., Dawson, Mark. A., M A Dawson, M ALLEN DAWSON, M Dawson, M. A. Dawson, M. Dawson

378

Publications

18.6K

Citations

H-Index

102

Concepts

All Affiliations

Peter MacCallum Cancer Centre The University of Melbourne Walter and Eliza Hall Institute of Medical Research University of Cambridge Monash University

About

Mark A. Dawson is an author at Peter MacCallum Cancer Centre specializing in medicine, cell biology, and chromatin.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	28	35	6.4K
2	Health Sciences	8	8	560
3	Natural Sciences	7	7	1.3K
4	Biochemistry	4	4	661
5	Allergy	1	1	10

Mark A. Dawson

Publications

11.4K

Citations

H-Index

Page 1

	Year	Citations
Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia Mark A. Dawson, Rab K. Prinjha, Antje Dittmann, Nature Hematological MalignancyChromatinBet RecruitmentMixed-phenotype Acute LeukemiaMalignant Blood Disorder	2011	1.5K
CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity Marian L. Burr, Christina E. Sparbier, Yih-Chih Chan, Nature Cancer ImmunosurveillanceMedicineImmunologyTumor ImmunityAnti-tumour Immunity	2017	910
JAK2 phosphorylates histone H3Y41 and excludes HP1α from chromatin Mark A. Dawson, Andrew J. Bannister, Berthold Göttgens, Nature Histone ModificationsChromatinTranscriptional RegulationChromatin StructureChromatin Remodeling	2009	600
An Evolutionarily Conserved Function of Polycomb Silences the MHC Class I Antigen Presentation Pathway and Enables Immune Evasion in Cancer Marian L. Burr, Christina E. Sparbier, Kah Lok Chan, Cancer Cell	2019	596
BET inhibitor resistance emerges from leukaemia stem cells Chun Yew Fong, Omer Gilan, Enid Y.N. Lam, Nature Hematological MalignancyCell TherapyBet Inhibitor ResistanceMedicineImmunology	2015	542
TET2 and TET3 regulate GlcNAcylation and H3K4 methylation through OGT and SET1/COMPASS Rachel Deplus, Benjamin Delatte, Marie K. Schwinn, The EMBO Journal ChromatinSignal TransductionBiochemistryNatural SciencesEpigenetic Change	2013	486
Ibrutinib plus Venetoclax for the Treatment of Mantle-Cell Lymphoma Constantine S. Tam, Mary Ann Anderson, Christiane Pott, New England Journal of Medicine	2018	417
Selective targeting of BD1 and BD2 of the BET proteins in cancer and immunoinflammation Omer Gilan, Inmaculada Rioja, Kathy Knezevic, Science	2020	411
Epigenetic silencing by the HUSH complex mediates position-effect variegation in human cells Iva A. Tchasovnikarova, Richard T. Timms, Nicholas J. Matheson, Science Epigenetic ChangeGeneticsGenomic MechanismEpigeneticsEpigenetic Silencing	2015	348
Two routes to leukemic transformation after a JAK2 mutation–positive myeloproliferative neoplasm Philip Beer, François Delhommeau, Jean-Pierre Lecouedic, Blood	2009	297

Page 1